What Types of Drugs Require ADA Testing?

ADA testing is essential for biologics, including monoclonal antibodies, therapeutic proteins, and gene therapies. As these drug types elicit immune responses, it is crucial to conduct ADA assessments during their development.

How Does the ADA Testing Impact Drug Development Timelines?

Depending on the complexity of the testing, results can influence timelines. Early identification of immunogenicity issues can facilitate modifications to drug formulations and dosing strategies, ultimately aiding in faster market access.

Is ADA Testing Required for All Clinical Trials?

While not all clinical trials require extensive ADA testing, guidelines from regulatory agencies recommend it for therapeutic biologics. It is essential for clinical trials in phases involving patient exposure to these products.